Biovail to Present at the Goldman Sachs Twenty-Eighth Annual Global Healthcare Conference



    TORONTO, June 7 /CNW/ - Biovail Corporation (NYSE:  BVF)(TSX:BVF) today
announced that the Company will present at the Goldman Sachs Twenty-Eighth
Annual Global Healthcare Conference at the Ritz-Carlton Laguna Niguel in Dana
Point, California.

    Biovail's presentation is scheduled for Wednesday, June 13, 2007, at
11:20 a.m. PDT (2:20 p.m. EDT). A live and archived Webcast, in addition to
presentation slides, will be available on the Investor Relations page of
Biovail's Web site at www.biovail.com.

    About Biovail Corporation

    Biovail Corporation is a specialty pharmaceutical company, engaged in the
formulation, clinical testing, registration, manufacture and commercialization
of pharmaceutical products utilizing advanced drug-delivery technologies. For
more information about Biovail, visit the Company's Web site at
www.biovail.com.

    For further information, please contact Nelson F. Isabel at 905-286-3000
or send inquiries to ir@biovail.com.




For further information:

For further information: Biovail Corporation Nelson F. Isabel, Vice
President, Investor Relations & Corporate Communications, 905-286-3000

Organization Profile

BIOVAIL CORPORATION

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890